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Abstract
Background: Perceived Health Related Quality of Life (HRQoL) is impaired in obstructive sleep apnea (OSA). To our
knowledge, no study has analyzed the effect of OSA diagnosis communication on HRQoL. We evaluated self-perceived
HRQoL in patients afferent to our sleep center, in order to examine the effect of the diagnosis disclosure on their
HRQoL.
Methods: Two hundred ninety-seven consecutive outpatients (227 M) (mean age 54.1 ± 11.6 yrs, range 23–80 yrs) were
evaluated, before first clinical visit and nocturnal diagnostic examination (Time A), and after diagnosis disclosure (Time
B), with two self-reported questionnaires for HRQoL assessment: Psychological General Well-Being Index (PGWBI),
consisting of anxiety, depressed mood, positive well-being, self-control, general health, vitality subscales, and 12-Item
Short-Form Health Survey (SF-12), comprising Physical (PCS) and Mental Component Summaries (MCS).
Results: Comparison of mean HRQoL scores at Time A with reference values, showed worse scores. Mean PGWBI Total
and subscales scores improved at Time B. Similar improvement was observed for SF-12 MCS (p = 0.0148), but nor for
SF-12 PCS. At Time B, Anxiety, Depression and Well-being PGWBI subscales became similar to reference values, while
the scores in the other PGWBI subscales and SF-12 remained worse. Comparison between males and females showed
higher HRQoL values for males at both times. Score changes were independent from age, gender, BMI, AHI, TSat90 and
excessive daytime sleepiness.
Conclusions: Diagnosis communication improves patients’ HRQoL, regardless of the severity. Changes in HRQoL after
diagnosis disclosure may be due to patients’ motivation for medical check and diagnostic expectations.
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Background
Obstructive sleep apnea (OSA) is characterized by re-
petitive episodes of complete or partial interruption of
ventilation during sleep, which is caused by a collapse in
the upper airway. Obstructive apneas are associated with
ongoing increasing respiratory efforts, intermittent hyp-
oxia, systemic and pulmonary arterial blood pressure
fluctuations and sleep disruption. Approximately 9 % of
women and 24 % of men in the general population have
sleep-disordered breathing and most of those affected
remain undiagnosed [1]; factors that increase susceptibil-
ity to the disorder include age, male sex, menopause,
obesity, craniofacial abnormalities, family history, and
health behaviours such as cigarette smoking and alcohol
use [2].
Patients with OSA may exhibit several typical symp-
toms including habitual snoring (often disruptive for bed
partners), feeling of unrefreshed awaking, excessive day-
time sleepiness (EDS), psychological disturbances [3, 4],
cognitive [5] and emotional disorders [6, 7] that may
also give rise to family and social conflict [8].
Perceived Health Related Quality of Life (HRQoL) are
deteriorated in sleep-disordered breathing. OSA patients
often report a poor HRQoL in social, emotional, and
physical domains [9, 10] partially explained by overlap-
ping symptoms including fatigue, loss of interest, de-
creased libido, and poor concentration [11]. Although
many studies have examined the HRQoL in OSA pa-
tients, highlighting its deterioration [7, 8, 10, 12, 13], as
far as we know, there are no studies that examine the
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effect of OSA diagnosis on HRQoL. Most studies have
assessed patients’ mood and HRQoL retrospectively,
after a diagnosis had already been disclosed, therefore
missing a comparison with the previous phase in which
patients were unaware of the diagnosis [7, 8, 10, 12, 13].
We have already evaluated the HRQoL of patients at
the first time visit, pointing out that EDS plays a major
role in determining a deterioration in HRQoL [14]. In
order to explore whether, and to what extent, disclosure
of the OSA diagnosis affects patients’ HRQoL, an assist-
ant psychologist administered unspecific disease ques-
tionnaires before the first examination and immediately
after diagnosis disclosure.
Aim of this study was to evaluate self-perceived well-
being in patients referred to a laboratory for sleep re-
lated breathing disorders, and to examine the effect of
the diagnosis disclosure on their HRQoL.
Methods
We performed a study involving patients afferent to our
Sleep Laboratory for OSA. Out of 450 consecutive out-
patients, 297 completed the study (70 F, 227 M), age 23–
80 yrs (54.1 ± 11.6). Patients with a prior diagnosis or
treatment for OSA were excluded (n. 84), as were sub-
jects who did not provide consent or did not complete
full diagnostic process or questionnaires (n. 66). Patients
affected by psychiatric or neurological diseases, diag-
nosed and pharmacologically treated, were also excluded
(n. 3). Subjects underwent a detailed evaluation that in-
cluded clinical history focused on sleep-related symp-
toms. The local ethical committee approved the protocol
and all subjects gave their written informed consent
prior to their inclusion.
For HRQoL evaluation, the Italian versions of Psycho-
logical General Well-Being Index (PGWBI) [15], and 12-
Item Short-Form Health Survey (SF-12) [16] were
administered. These tools were given together to guaran-
tee a further extension of HRQoL measures.
Nocturnal monitoring was performed with a portable
computerized system (Somté or Somnea Compumedics
Inc.; Abbotsford, VIC, Australia). The recorded signals
were airflow, snoring, thoracic and abdominal effort,
limb movement, body position, arterial oxygen satur-
ation, pulse rate, and pulse waveform. Duration of re-
cordings was at least 6 h. Apneas and hypopneas were
visually scored. According to American Academy of
Sleep Medicine Task Force (AASM) standard criteria
[17] apneas were defined as lack of airflow for at least
10s and hypopneas were defined as discernible reduc-
tions in airflow or thoracic and abdominal movements
for at least 10s followed by an arterial oxygen saturation
fall >3 %. Apnea-hypopnea index (AHI) was calculated
as number of apneas and hypopneas per hour of esti-
mated total sleep time. OSA severity is defined as mild,
5 to 15 events per hour; moderate, 15 to 30 events per
hour; severe, greater than 30 events per hour [18].
Percent night-time with O2 saturation <90 % (TSat90)
was evaluated.
Questionnaires
The Psychological General Well-Being Index (PGWBI)
was used to measure perceived psychological well-being
[15, 19]. The responses to 22 questions are arranged in
six subscales: anxiety (five items), depressed mood (three
items), positive well-being (four items), self-control
(three items), general health (three items) and vitality
(four items). Item responses are rated on a six-point
Likert scale ranging from 0 (highest possible distress) to
5 (completely healthy status). The six-scale scores were
computed by summing the relevant items. Higher scores
indicate better health. The six scales can be further
summed to provide a global index score representing
one’s comprehensive subjective well-being ranging from
0 to 110. A global score <60 suggests a Severe Distress;
from 60 to 72 suggests a Moderate Distress; and >72
suggests No Distress. It was already used to evaluate
HRQoL at first time visit in our sleep centre [14].
The 12-Item Short-Form Health Survey (SF-12), is the
shorter health self-administered questionnaire derived
from the SF-36, allowing faster assessment of patients
and producing physical and emotional component sum-
maries without any substantial loss of information com-
pared to the SF-36 [16, 20]. Two subscales are derived
from the SF-12: the Physical Component Summary
(PCS) and the Mental Component Summary (MCS).
The PCS includes questions about physical functioning,
role limitations due to physical health problems, bodily
pain and general health. The MCS includes questions
about vitality (energy/fatigue), social functioning, role
limitations due to emotional problems, and mental
health (psychological distress and psychological well-
being). The PCS and MCS are standardised to a mean of
about 50, with a score above 50 representing better than
average function and below 50 poorer than average func-
tion [20].
The Italian version of Epworth Sleepiness Scale (ESS)
[21, 22] was administered to assess daytime sleepiness.
Patients rated the likelihood of falling asleep in eight
specific situations on a 0–3 scale, with 0 meaning no
chance at all of falling asleep, and 3 representing a high
chance of falling asleep. Thus, the scale goes from 0 to
24. A score > 10 suggests EDS.
Study procedure
Patients’ HRQoL was assessed at the first visit (Time A),
and immediately after diagnosis disclosure (Time B).
The study affected neither the patients’ diagnostic pro-
cedure and care routine nor the timing of diagnosis
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communication. The patients underwent the sleep study
3–18 days after first visit. Between first visit and diagno-
sis communication 15–30 days occurred. In order to
reach uniformity and to avoid an effect on responses,
questionnaires were administered in the same order: ESS
only at Time A, and PGWBI, followed by SF-12 at Time
A and Time B.
Diagnosis of OSA was considered disclosed after the
physician had informed the patient about the nature of the
condition and therapeutic procedures, when appropriate.
Treatments were recommended for OSA patients with an
AHI ≥15, regardless of symptoms, and for patients with an
AHI ≥5 events per hour accompanied by symptoms (EDS,
impaired cognition, etc.) or comorbidities.
After second administration (Time B), the patients
were briefed about HRQoL questionnaires results evalu-
ated at Time A.
Statistical analysis
Difference between means was assessed by the non-
parametric Wilcoxon test. Difference between means at
Time A and Time B was evaluated by paired t-test. Pear-
son’s chi-square was applied to assess differences in
distress categories at Time A and Time B if any. Relation-
ships between selected variables were identified through
simple linear regression. Data were reported as mean ±
SD. A p < 0.05 was considered significant. Statistical ana-
lysis was performed by commercial software (JMP 8.0 SAS
Institute Inc.).
Results
Sample characteristics and nocturnal polygraphic results
for total population and for males and females are re-
ported in Table 1.
Table 2 shows PGWBI and SF-12 reference values as
reported by the questionnaires manuals [15, 16], and
sample scores at Time A and B. Mean HRQoL scores at
Time A were worse than reference values. At Time B
Anxiety, Depression and Well-being PGWBI subscales
improved and became similar to reference values, while
the scores in other PGWBI subscales and SF-12
remained worse.
PGWBI scores at Time B were improved compared to
Time A, similar improvement was observed for SF-12
MCS (p = 0.0148), but not for SF-12 PCS (Table 2). Ap-
plying criteria for minimal important change (4 points
difference for PGWBI and 2 points for each summary of
SF-12) [16, 23] the difference observed at Time B for
mean PGWBI Total score was clinically meaningful.
Moreover, comparing Time A with reference values, the
mean PGWBI Total Score was clinically lower. Con-
versely, at Time B, the mean score was not different
from reference values. No clinically meaningful differ-
ence was observed in SF-12.
Table 3 shows sample distribution for distress categor-
ies at Time A and B, as reported in PGWBI Manual
[15]. Distribution among categories was different be-
tween Time A and B (chi-square = 6.99; p < 0.04). At
Time B subjects with No-Distress increased, while those
with Severe and Moderate Distress decreased. There
were no changes in distress categories in 136 subjects
with No-Distress, 29 with Moderate Distress and 52 with
Severe Distress.
Comparison between males and females showed better
HRQoL values for males at both times. After diagnosis
communication males improved all scores except one
(SF-12 PCS), while females improved only in Total
Score, Anxiety, Well-Being, Health and Vitality PGWBI
subscales (Table 4).
Linear regression analysis between HRQoL scores at
Time B minus Time A, and age, gender, body mass
index (BMI), AHI, Tsat90 and ESS did not show any sig-
nificant relationship.
Discussion
The results of this study show that communication of
OSA diagnosis has an impact on patients’ HRQoL. At
first visit (Time A), our sample had worse scores than
reference values [15, 16]. The assessment of patients,
showed a significant improvement in HRQoL as evalu-
ated by PGWBI subscales and in SF-12 MCS after the
diagnosis communication, irrespective of OSA severity.
At Time B, the scores of Anxiety, Depression and Well-
Table 1 Summary of patient characteristics and nocturnal
polygraphic results
Total Female Male
Subjects, No. 297 70 227
Age, yrs 54.1 ± 11.6 58.9 ± 10.2 52.6 ± 11.7*
(23–80) (36–80) (23–80)
BMI, kg/m2 31.3 ± 6.2 32.8 ± 7.1 30.8 ± 5.9
(19.1–50.8) (19.1–50.8) (19.5–49.9)
AHI, n/h 35.5 ± 25.6 34.1 ± 29.3 35.9 ± 24.4
(0–118) (0–118) (0–97)
Normal, No. (%) 25 (8.4) 10 (14.3) 15 (6.6)
Mild, No. (%) 63 (21.2) 17 (24.3) 46 (20.3)
Moderate, No. (%) 61 (20.5) 12 (17.1) 49 (21.6)
Severe, No. (%) 148 (49.8) 31 (44.3) 117 (51.5)
TSat90, % 16.6 ± 21.3 19.4 ± 25.2 15.8 ± 19.9
(0–90) (0–81.8) (0–90)
ESS score 9.5 ± 5.2 9.3 ± 5.6 9.5 ± 5.1
(0–24) (0–22) (0–24)
Data are presented as mean ± SD (range). BMI, body mass index; AHI, Apnea
hypopnea index; TSat90, percent night-time at less than 90 % oxygen
saturation; ESS, Epworth Sleepiness Scale.
*p < 0.0001 vs Female.
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being PGWBI subscales improved and were similar to
those of the reference values [15, 16]. Sample distribu-
tion for PGWBI descriptive distress categories at Time B
showed an increase of subjects in the No-Distress cat-
egory. Females reported lower scores than males in both
questionnaires, and lower improvements at Time B. Using
the criteria for minimal important change [16, 23], scores
variation was independent of age, BMI, AHI, TSat90 and
EDS.
As far as we know, no study has investigated the effect
of being informed of OSA diagnosis on HRQoL. Most
available studies concern the effect of cancer diagnosis
communication, but findings are controversial. Some
data support a positive effect of the knowledge of a can-
cer diagnosis [24] whereas others suggest that diagnosis
worsens patients’ HRQoL [25]. Differences in the ques-
tionnaires, study design and cultural backgrounds could
account for these divergent results. A study on effect of
multiple sclerosis diagnosis shows that its disclosure im-
proves patients’ psychological well-being [26]. As con-
cerns OSA, Głebocka et al. [27], did not find any
significant psychological disturbances in OSA patients,
interviewed before starting treatment, as compared to nor-
mal healthy adults. The authors attributed this unexpected
lack of psychological differences to the rapid mood im-
provement in OSA patients on anticipation of being diag-
nosed and taken care of in the hospital setting [27].
HRQoL among subjects afferent to our sleep center
for suspicion of OSA was impaired as we already ob-
served in a previous study [14], and improved after diag-
nosis communication. Splitting the sample by gender,
women showed a worse HRQoL than men. Similar re-
sults were observed in many other studies, despite they
adopted other HRQoL or mood evaluation instruments
[28, 29]. Women in a healthy population, report poorer
well-being and have a higher symptom complaint rate
[30]. Gender differences could be explained by women
characteristics such as greater bodily attention, as well
as social acceptance for women to express distress [31].
In our sample, after diagnosis communication, both gen-
ders showed an improved HRQoL. Male subjects re-
ported improvement in all PGWBI subscales and SF-12
MCS, while females improved PGWBI Total score, and
Anxiety, Well-Being, Health and Vitality subscales. Sev-
eral reasons may be involved in this positive effect. Ap-
proach of the clinical staff may be important when
patients are made aware of their physical conditions.
Changes in HRQoL scores at Time B were independ-
ent from age, BMI, severity of disease (AHI), nocturnal
hypoxia and EDS. Dutt et al. [32] observed that the
HRQoL impairment was not proportional to OSA sever-
ity. D’Ambrosio et al. [10] noted that all dimensions of
the HRQoL were significantly impaired in OSA patients
as compared to the normal population, but did not ob-
serve any correlation between increase in severity illness
and HRQoL burden [29]. In another study [33], the au-
thors conclude that the altered HRQoL of patients with
sleep-related breathing disorders is a multifactorial
phenomenon depending on the interaction among sleep
stages, daytime sleepiness and obesity, with no signifi-
cant contribution of sleep fragmentation, hypoxemia and
apnea recurrence. The physiological parameters alone
may not be the only determinants of the extent of pa-
tients’ disturbance and they can not be taken as a
marker of HRQoL [32].
Since the relationship between symptoms and HRQoL
is neither simple nor direct, there is a need for a
complete evaluation, considering physiological, emo-
tional, and social impairment of each patient, assessing
well-being independently of OSA severity. To examine
Table 2 Health-related quality of life data by PGWBI and SF-12
RV Time A Time B p values Time A vs RV p values TimeB vs RV p values Time A vs Time B
PGWBI 78.0 ± 17.9 70.4 ± 17.3 74.4 ± 17.9 p < 0.0001 p = 0.0004 p < 0.0001
Anxiety 17.3 ± 5.0 15.8 ± 4.7 17.1 ± 4.6 p < 0.0001 NS p < 0.0001
Depression 12.4 ± 2.6 12.0 ± 2.7 12.3 ± 2.6 p = 0.0053 NS p = 0.0009
Well-being 11.8 ± 4.0 11.2 ± 3.8 11.8 ± 3.8 p = 0.0113 NS p < 0.0001
Self-control 11.8 ± 2.7 10.9 ± 3.0 11.3 ± 3.1 p < 0.0001 p = 0.0016 p = 0.0104
Health 11.1 ± 3.0 9.5 ± 2.8 10.2 ± 2.7 p < 0.0001 p < 0.0001 p < 0.0001
Vitality 13.4 ± 4.0 10.9 ± 4.0 11.6 ± 4.0 p < 0.0001 p < 0.0001 p < 0.0001
SF-12 PCS 50.0 ± 9.5 45.0 ± 9.7 45.5 ± 9.9 p < 0.0001 p < 0.0001 NS
SF-12 MCS 50.1 ± 10.0 45.4 ± 10.8 46.5 ± 10.8 p < 0.0001 p < 0.0001 p = 0.0148
Data are presented as mean ± SD. PGWBI, Psychological General Well-Being Index; SF-12, 12-Item Short-Form Health Survey; PCS, Physical Component Summary;
MCS, Mental Component Summary; RV, Reference Values; Time A, first time visit; Time B, after diagnosis communication.
Table 3 Sample distribution for PGWBI descriptive distress
categories before and after diagnosis
No-distress Moderate distress Severe distress
Time A 145 73 79
Time B 177 56 64
Contingency table reporting number of subjects for distress categories at Time
A and Time B.
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the effect of the diagnosis communication on HRQoL in
patients referred to a sleep laboratory, we have also
assessed HRQoL of non-OSA subjects reporting a wide
range of symptoms and disease severity that led them to
consult a sleep center. Therefore, someone with an ex-
perience of poor health and low expectations about his
health status might not consider OSA diagnosis as hav-
ing an adverse impact, but could even feel less distressed
after diagnosis, as solutions to perceived symptoms may
be found. Conversely, Garr et al. pointed out that some-
one who generally has good health might experience a
significant negative impact on HRQoL from a relatively
minor illness [34]. Recognition of OSA implies, in some
cases, the use of chronic therapies, like continuous posi-
tive airway pressure (CPAP), that could cause significant
distress to the patient. However, some implications
could be relevant even in case of negative diagnosis,
since waiting for an exhaustive diagnosis may keep the
patient in a state of psychological distress, especially
when further checks are needed to explain the symp-
toms. So, changes in HRQoL after the communication
of OSA diagnosis may depend on health expectations,
symptoms perceived, environmental and individual char-
acteristics, patients’ motivation for medical check and
the relationship between physician and patient. Never-
theless, the findings suggest that OSA diagnosis know-
ledge together with disease explanation may promote
the process of adaptation to the disease with an im-
provement in psychological well-being.
Our study has some limitations, the most important
being related to the different size of males and females
subgroups. Further studies are needed to assess gender
differences and to investigate diagnostic expectations at
first visit. Despite these limitations, this study provides
initial evidence that OSA diagnosis communication has
an impact on HRQoL, probably influenced by personal
and environmental factors.
Conclusions
Disclosure of OSA diagnosis affects patients’ well-being.
In our sample, diagnosis communication improves pa-
tients’ HRQoL, regardless of OSA severity and anthropo-
metric characteristics. HRQoL investigation appears useful
for a complete assessment of each patient disturbance,
analyzing physiological and emotional impairments.
Patients’ motivation for medical check and diagnostic ex-
pectations should be taken into account during HRQoL
assessment, to schedule specific interventions to support
and promote well-being, and to improve patient-physician
relationship.
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